Skip to main content
Jul 03, 2023

SiriusPoint names new legal chief

Linda Lin to join insurer and reinsurer on July 24

NYSE-listed specialty insurer and reinsurer SiriusPoint has appointed Linda Lin as chief legal officer, effective July 24.

Lin will join the company’s executive leadership team, reporting to CEO Scott Egan, and will be based in New York. Jimmy Yang, who became interim general counsel in February of this year, will work with Lin on a transition.

Lin will join SiriusPoint from Coaction Global (formerly Prosight), where she was general counsel and corporate secretary, leading the firm’s legal, regulatory, compliance, product development and internal audit functions. Before that, she was senior vice president, general counsel and co-head of regulatory matters at QBE North America.

Linda Lin


Earlier in her career, Lin held various legal, claims and product development roles at Berkshire Hathaway Specialty Insurance and Liberty International Underwriters. Before moving in-house, she was a litigator with law firm Willkie Farr & Gallagher. She is also president of the Sotomayor Program, which develops future legal leaders from underserved communities and diverse backgrounds.

Egan says in a statement: ‘As a highly experienced general counsel with a broad legal background in the re/insurance and listed environments, I have no doubt that Linda will be an enormous asset in helping us deliver against our ambitious strategy. I am delighted that she is bringing her expertise to SiriusPoint and further strengthening our deep bench of executive talent in the areas of leadership and culture building.

‘I am very grateful to Jimmy for the contribution he has made as interim [general counsel]. He has been invaluable to the progress we have made in the last nine months.’

 

Ben Maiden

Ben Maiden is the editor-at-large of Governance Intelligence, an IR Media publication, having joined the company in December 2016. He is based in New York. Ben was previously managing editor of Compliance Reporter, covering regulatory and compliance...

More on